Pharmaceutical preparations for use in treating diseases of the cardiovascular system and cerebrovascular system; Pharmaceutical preparations for use in treating cancerous tumors; Pharmaceutical preparations for use in treating metabolic diseases and diseases of the immune system and the musculo-skeletal system; Chemical preparations for pharmaceutical or medical purposes, namely, Pharmaceutical preparations for use in haematology, dermatology, ophthalmology and gastroenterology, Pharmaceutical preparations being anti-infectives, Pharmaceutical preparations for use in treating diseases of the respiratory system, the digestive system, and the endocrine system, Pharmaceutical preparations for use in treating hypersensitivity diseases; Medicines for human purpose for treating disease, namely, pharmaceutical preparations for use in treating diseases of the cardiovascular system and cerebrovascular system, pharmaceutical preparations for use in treating cancerous tumors, pharmaceutical preparations for use in treating metabolic diseases, as well as diseases of the immune system and the musculo-skeletal system; Active pharmaceutical ingredients in the nature of pharmaceutical preparations used for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, and the musculo-skeletal system, and for treating cancerous tumors; Biochemical medicines for use in treating diseases of the cardiovascular system and cerebrovascular system; Biochemical medicines for use in treating cancerous tumors; Biochemical medicines for use in treating metabolic diseases, nervous system diseases as well as diseases of the immune system and the musculo-skeletal system; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the metabolic system, the respiratory system, and the musculo-skeletal system, pharmaceutical preparations for use in tissue and organ transplantation, for use in ophthalmology and for use in treatment of gastroenterological disorders

Mark Details

Serial Number

No 88133406

Mark Type

No Service/Collective Mark

Attorney Docket Number

No ACIP0734

44D Filed

44D Current

44E filed

44E Current

66A Filed

66A Current

Current Basis

No Basis

Legal History

Status Date	Action Taken
07^th Jan 2020	REGISTERED-PRINCIPAL REGISTER
22^nd Oct 2019	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
22^nd Oct 2019	PUBLISHED FOR OPPOSITION
02^th Oct 2019	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
18^th Sep 2019	APPROVED FOR PUB - PRINCIPAL REGISTER
09^th Aug 2019	NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09^th Aug 2019	EXAMINER'S AMENDMENT ENTERED
09^th Aug 2019	EXAMINERS AMENDMENT E-MAILED
09^th Aug 2019	EXAMINERS AMENDMENT -WRITTEN
07^th Aug 2019	TEAS VOLUNTARY AMENDMENT RECEIVED

SALUBRIS

Classification Information

Class [005]Pharmaceutical Products